In the BioHarmony Drug Report Database

"Preview" Icon

Pirfenidone

Esbriet (pirfenidone) is a small molecule pharmaceutical. Pirfenidone was first approved as Esbriet on 2011-02-27. It is used to treat pulmonary fibrosis in the USA. It has been approved in Europe to treat idiopathic pulmonary fibrosis. Esbriet’s patents are valid until 2037-03-28 (FDA).

 

Trade Name

 

Esbriet
 

Common Name

 

pirfenidone
 

ChEMBL ID

 

CHEMBL1256391
 

Indication

 

idiopathic pulmonary fibrosis, pulmonary fibrosis
 

Drug Class

 

Image (chem structure or protein)

Pirfenidone structure rendering